Prostate cancer decisions — 2022

The Veteran's claims for service connection for prostate cancer, erectile dysfunction as secondary to prostate cancer, and urinary incontinence as secondary to prostate cancer have all been denied. The Board found that the evidence did not support a finding of herbicide exposure on a facts-found or direct basis during active service.

The Board has granted service connection for gastroesophageal reflux disease (GERD) with duodenal bulb scarring, but denied service connection for basal cell carcinoma, bladder cancer, non-Hodgkin's lymphoma, and prostate cancer due to lack of evidence linking these conditions to in-service exposure or service.

The Veteran's prostate cancer residuals have been rated at a noncompensable level prior to July 22, 2019. From July 22, 2019 to May 23, 2021, the Veteran is granted a 10 percent rating for urinary frequency resulting in awakening from sleep two times per night.

The Board denied service connection for prostate cancer as there was no evidence of exposure to contaminants that could have caused the condition, and the Veteran's claim is not supported by the weight of the medical evidence.

The Veteran's prostate cancer was previously rated at 100% but the rating has been reduced to 20%. The appeal is for an increased rating of residuals of prostate cancer, which remains denied.

The Board denied service connection for prostate cancer and throat cancer, finding no evidence of herbicide exposure in service or a direct link to service.

The Board has denied service connection for prostate cancer, finding that the Veteran's prostate cancer was not caused by his active duty service. The Board has also remanded the issue of service connection for ankylosing spondylitis.,Service connection will be determined based on whether there is a link between the current disability and the in-service disease or injury.

The Board has determined that the Veteran's prostate cancer is not related to service, including his exposure to petroleum-related chemicals as a petroleum supply specialist. The claim for service connection is denied.

The Veteran's tinnitus is granted service connection. The Board has remanded the claims for restless leg syndrome, low back disability, Morton's neuroma of the left foot, prostate cancer, lung disability, and dental disability due to lack of nexus opinions.

The Board denied service connection for prostate cancer, heart disease (claimed as atrial fibrillation and ischemic heart disease), and erectile dysfunction. The Veteran was not shown to have had exposure to herbicide agents during his military service.

The Veteran's prostate cancer is presumed to have been caused by exposure to herbicide agents during service, and the appeal for service connection is granted.

The Veteran's prostate cancer is due to his time in service, specifically exposure to herbicide agents near the perimeter of a Thai military base. Service connection for prostate cancer is granted on a presumptive basis.

The Board denied service connection for lung cancer and prostate cancer, both of which were diagnosed after the Veteran's death. The Board found that there was no evidence to support a finding that these conditions were incurred in or due to the Veteran's time in service.

The Veteran's prostate cancer is granted service connection as related to herbicide exposure on Okinawa. The claim for left lower extremity peripheral neuropathy and TDIU remains pending.

The Board has determined that the Veteran's claims for service connection are remanded due to new and material evidence having been received. The specific issues of entitlement to service connection have not yet been addressed.

The Board has dismissed all appeals for service connection for various conditions claimed as the result of ionizing radiation exposure.

The rating reduction from 100 percent to 60 percent disabling for the Veteran's service-connected urinary incontinence (previously rated as prostate cancer) was proper and effective since June 1, 2017. The Veteran is currently evaluated at 60 percent for urinary incontinence.

The Board has remanded the cases for further development and clarification of the Veteran's prostate cancer diagnosis, as well as to obtain an addendum opinion regarding whether his prostate cancer is related to service. The right shoulder arthritis and erectile dysfunction claims are also being remanded.

The Board has granted service connection for prostate cancer and coronary artery disease, both presumed to be caused by herbicide exposure during active duty. Vascular disease was denied as not related to service.

The Veteran's prostate cancer is granted as service connected due to exposure to herbicide agents in Thailand during his military service.